Never Share an Insulin Glargine, U-300 SoloStar or Insulin Glargine, U-300 Max SoloStar Pen Between Patients Advise patients that they must never share Insulin Glargine, U-300 SoloStar or Insulin Glargine, U-300 Max SoloStar pen with another person even if the needle is changed
Our providers work with you to determine what monitoring (if any) makes sense based on your health status, goals, and preferences
As a result, patients often experience reduced cravings, improved portion control, and steadier progress over time
GI side effects and dose relationship Gastrointestinal symptoms are the most common adverse events reported with retatrutide, and they follow a clear dose-dependent pattern
We want people feeling better
Vomiting: typically improves with time